Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
James River Group Holdings Ltd is an insurance-specialty business based in the US. James River Group shares (JRVR) are listed on the NASDAQ and all prices are listed in US Dollars. James River Group employs 638 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $24.60 |
|---|---|
| 52-week range | $19.67 - $38.97 |
| 50-day moving average | $24.41 |
| 200-day moving average | $27.66 |
| Wall St. target price | $31.25 |
| PE ratio | N/A |
| Dividend yield | $0.95 (0.84%) |
| Earnings per share (TTM) | $-1.64 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $24.6 from 2022-06-24
| 1 week (2022-06-17) | 6.77% |
|---|---|
| 1 month (2022-05-27) | -6.25% |
| 3 months (2022-03-25) | 12.59% |
| 6 months (2021-12-27) | -11.38% |
| 1 year (2021-06-25) | -33.37% |
|---|---|
| 2 years (2020-06-26) | -43.47% |
| 3 years (2019-06-27) | 46.28 |
| 5 years (2017-06-27) | 40.04 |
Valuing James River Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of James River Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
James River Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $29 million.
The EBITDA is a measure of a James River Group's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $791.8 million |
|---|---|
| Gross profit TTM | $-19,472,000 |
| Return on assets TTM | -0.36% |
| Return on equity TTM | -8.26% |
| Profit margin | -7.47% |
| Book value | $17.30 |
| Market capitalisation | $921.3 million |
TTM: trailing 12 months
We're not expecting James River Group to pay a dividend over the next 12 months.
Over the last 12 months, James River Group's shares have ranged in value from as little as $19.6748 up to $38.9738. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while James River Group's is 0.4006. This would suggest that James River Group's shares are less volatile than average (for this exchange).
James River Group Holdings, Ltd. , through its subsidiaries, provides specialty insurance and reinsurance services in the United States. It operates through Excess and Surplus Lines, Specialty Admitted Insurance, and Casualty Reinsurance segments. The Excess and Surplus Lines segment underwrites liability and property insurance on an excess and surplus commercial lines basis in all states and the District of Columbia. This segment distributes its insurance policies primarily through wholesale insurance brokers. The Specialty Admitted Insurance segment provides workers' compensation coverage for building trades, healthcare employees, goods and services, light manufacturing, specialty transportation, and agriculture, as well as fronting and program business. The Casualty Reinsurance segment offers proportional and working layer casualty reinsurance to third parties and other insurance companies.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.